Topic: plant remediation

Sun says 'time consuming' remediation paying off

Sun Pharma continues to slog away at its remediation efforts at both its key plant in Halol as well at the four plants it got in its $4 billion buyout of Ranbaxy Laboratories that are banned by the FDA from shipping to the U.S. But Sun Managing Director Dilip Shanghvi says progress is being made on both fronts.